Cliff Asness's WVE Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 451,185 shares of Wave Life Sciences Ltd. (WVE) worth $3.27 M, representing 0.00% of the portfolio. First purchased in 2018-Q2, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in WVE, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 248,464 shares. Largest reduction occurred in Q1 2022, reducing 77,561 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Wave Life Sciences (WVE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Wave Life Sciences (WVE) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +248,464 | Add 122.56% | 451,185 | $7.25 |
| Q4 2025 | +192,023 | Add 1794.94% | 202,721 | $17.00 |
| Q3 2025 | +10,698 | New Buy | 10,698 | $7.32 |
| Q2 2025 | -16,093 | Sold Out | 0 | $0.00 |
| Q1 2025 | -2,143 | Reduce 11.75% | 16,093 | $8.08 |
| Q4 2024 | -5,709 | Reduce 23.84% | 18,236 | $12.37 |
| Q3 2024 | -9,584 | Reduce 28.58% | 23,945 | $8.20 |
| Q2 2024 | +6,973 | Add 26.26% | 33,529 | $4.99 |
| Q1 2024 | +15,388 | Add 137.79% | 26,556 | $6.17 |
| Q4 2023 | +95 | Add 0.86% | 11,168 | $5.05 |
| Q3 2023 | +11,073 | New Buy | 11,073 | $5.75 |
| Q1 2022 | -77,561 | Sold Out | 0 | $0.00 |
| Q4 2021 | +77,561 | New Buy | 77,561 | $3.15 |
| Q2 2021 | -40,058 | Sold Out | 0 | $0.00 |
| Q1 2021 | -18,458 | Reduce 31.54% | 40,058 | $5.62 |
| Q4 2020 | +58,516 | New Buy | 58,516 | $7.88 |
| Q1 2019 | -12,624 | Sold Out | 0 | $0.00 |
| Q4 2018 | -1,204 | Reduce 8.71% | 12,624 | $42.06 |
| Q3 2018 | +2,946 | Add 27.07% | 13,828 | $49.97 |
| Q2 2018 | +10,882 | New Buy | 10,882 | $38.23 |
Cliff Asness's Wave Life Sciences Investment FAQs
Cliff Asness first purchased Wave Life Sciences Ltd. (WVE) in Q2 2018, acquiring 10,882 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Wave Life Sciences Ltd. (WVE) for 20 quarters since Q2 2018.
Cliff Asness's largest addition to Wave Life Sciences Ltd. (WVE) was in Q1 2026, adding 451,185 shares worth $3.27 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 451,185 shares of Wave Life Sciences Ltd. (WVE), valued at approximately $3.27 M.
As of the Q1 2026 filing, Wave Life Sciences Ltd. (WVE) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Wave Life Sciences Ltd. (WVE) was 451,185 shares, as reported at the end of Q1 2026.